# Perampanel in Focal Status Epilepticus

> **NCT04309721** · PHASE3 · TERMINATED · sponsor: **Assistance Publique - Hôpitaux de Paris** · enrollment: 1 (actual)

## Conditions studied

- Epilepticus; Status, Focal Motor

## Interventions

- **DRUG:** Perampanel
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT04309721
- **Lead sponsor:** Assistance Publique - Hôpitaux de Paris
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2022-11-02
- **Primary completion:** 2022-11-02
- **Final completion:** 2023-11-13
- **Target enrollment:** 1 (ACTUAL)
- **Why stopped:** Lack of inclusion
- **Last updated:** 2023-12-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04309721

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04309721, "Perampanel in Focal Status Epilepticus". Retrieved via AI Analytics 2026-06-15 from https://api.ai-analytics.org/clinical/NCT04309721. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*